Literature DB >> 34642734

Impact of Reverse Causation on Estimates of Cancer Risk Associated With Radiation Exposure From Computerized Tomography: A Simulation Study Modeled on Brain Cancer.

Mark P Little, Ankur Patel, Choonsik Lee, Michael Hauptmann, Amy Berrington de Gonzalez, Paul Albert.   

Abstract

Use of computed tomography (CT) scanning has increased substantially since its introduction in the 1990s. Several authors have reported increased risk of leukemia and brain tumors associated with radiation exposure from CT scans. However, reverse causation is a concern, particularly for brain cancer; in other words, the CT scan may have been taken because of preexisting cancer and therefore not have been a cause. We assessed the possibility of reverse causation via a simulation study focused on brain tumors, using a simplified version of the data structure for recent CT studies. Five-year-lagged and unlagged analyses implied an observed excess risk per scan up to 70% lower than the true excess risk per scan, particularly when more than 10% of persons with latent cancer had increased numbers of scans or the extra scanning rate after development of latent cancer was greater than 2 scans/year; less extreme values of these parameters imply little risk attenuation. Without a lag and when more than 20% of persons with latent cancer had increased scans-an arguably implausible scenario-the excess risk per scan was increased over the true excess risk per scan by up to 35%-40%. This study suggests that with a realistic lag, reverse causation results in downwardly biased risk, a result of induced classical measurement error, and is therefore unlikely to produce a spurious positive association between cancer and radiation dose from CT scans. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  brain tumors; computed tomography; ionizing radiation; reverse causation; simulation studies

Mesh:

Year:  2022        PMID: 34642734      PMCID: PMC8898001          DOI: 10.1093/aje/kwab247

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  22 in total

1.  Reverse causation and confounding-by-indication: do they or do they not explain the association between childhood antibiotic treatment and subsequent development of respiratory illness?

Authors:  I Kummeling; C Thijs
Journal:  Clin Exp Allergy       Date:  2008-06-28       Impact factor: 5.018

2.  Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007.

Authors:  Fred A Mettler; Mythreyi Bhargavan; Keith Faulkner; Debbie B Gilley; Joel E Gray; Geoffrey S Ibbott; Jill A Lipoti; Mahadevappa Mahesh; John L McCrohan; Michael G Stabin; Bruce R Thomadsen; Terry T Yoshizumi
Journal:  Radiology       Date:  2009-09-29       Impact factor: 11.105

3.  Risks from CT scans--what do recent studies tell us?

Authors:  Linda Walsh; Roy Shore; Anssi Auvinen; Thomas Jung; Richard Wakeford
Journal:  J Radiol Prot       Date:  2014-03-04       Impact factor: 1.394

4.  Confounding by indication: an example of variation in the use of epidemiologic terminology.

Authors:  M Salas; A Hofman; B H Stricker
Journal:  Am J Epidemiol       Date:  1999-06-01       Impact factor: 4.897

5.  Childhood CT scans and cancer risk: impact of predisposing factors for cancer on the risk estimates.

Authors:  N Journy; T Roué; E Cardis; H Ducou Le Pointe; H Brisse; J-F Chateil; D Laurier; M-O Bernier
Journal:  J Radiol Prot       Date:  2016-02-15       Impact factor: 1.394

6.  NCICT: a computational solution to estimate organ doses for pediatric and adult patients undergoing CT scans.

Authors:  Choonsik Lee; Kwang Pyo Kim; Wesley E Bolch; Brian E Moroz; Les Folio
Journal:  J Radiol Prot       Date:  2015-11-26       Impact factor: 1.394

7.  Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.

Authors:  Mark S Pearce; Jane A Salotti; Mark P Little; Kieran McHugh; Choonsik Lee; Kwang Pyo Kim; Nicola L Howe; Cecile M Ronckers; Preetha Rajaraman; Alan W Sir Craft; Louise Parker; Amy Berrington de González
Journal:  Lancet       Date:  2012-06-07       Impact factor: 79.321

8.  Using simulation studies to evaluate statistical methods.

Authors:  Tim P Morris; Ian R White; Michael J Crowther
Journal:  Stat Med       Date:  2019-01-16       Impact factor: 2.497

9.  Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands.

Authors:  Johanna M Meulepas; Cécile M Ronckers; Anne M J B Smets; Rutger A J Nievelstein; Patrycja Gradowska; Choonsik Lee; Andreas Jahnen; Marcel van Straten; Marie-Claire Y de Wit; Bernard Zonnenberg; Willemijn M Klein; Johannes H Merks; Otto Visser; Flora E van Leeuwen; Michael Hauptmann
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

10.  A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.

Authors:  Radhika Dhingra; Andrea Winquist; Lyndsey A Darrow; Mitchel Klein; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2016-08-16       Impact factor: 9.031

View more
  2 in total

Review 1.  Cancer risks among studies of medical diagnostic radiation exposure in early life without quantitative estimates of dose.

Authors:  Mark P Little; Richard Wakeford; Simon D Bouffler; Kossi Abalo; Michael Hauptmann; Nobuyuki Hamada; Gerald M Kendall
Journal:  Sci Total Environ       Date:  2022-03-26       Impact factor: 10.753

Review 2.  Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses.

Authors:  Mark P Little; Richard Wakeford; Simon D Bouffler; Kossi Abalo; Michael Hauptmann; Nobuyuki Hamada; Gerald M Kendall
Journal:  Environ Int       Date:  2021-12-24       Impact factor: 13.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.